Application 219048
- Type
- ANDA
- Sponsor
- OMNIVIUM PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OLANZAPINE | OLANZAPINE | POWDER;INTRAMUSCULAR | 10MG/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219048-001 | OLANZAPINE | OLANZAPINE | 10MG/VIAL | POWDER / INTRAMUSCULAR | AP | 2026-01-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219048-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219048-001 | OLANZAPINE | 10MG/VIAL | POWDER / INTRAMUSCULAR | AP | 2026-01-23 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A219048-001 | OLANZAPINE | 10MG/VIAL | POWDER / INTRAMUSCULAR | AP | 2026-01-23 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219048-001 | OLANZAPINE | 10MG/VIAL | POWDER / INTRAMUSCULAR | AP | 2026-01-23 | 011fe1cb6892… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219048-001 | OLANZAPINE | 10MG/VIAL | POWDER / INTRAMUSCULAR | AP | 2026-01-23 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219048-001 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A219048-001 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A219048-001 | AP | 1 | 011fe1cb6892… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219048-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olanzapine | OLANZAPINE | NCS HealthCare of KY, LLC dba Vangard Labs | 87b7fb23-c9b7-433f-bd17-cd3e91714c27 | 2025-03-03 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Direct_Rx | fcec190f-b865-c5d3-e053-6394a90a7e45 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Direct_Rx | 22528ae1-e36f-48e1-e063-6294a90a3dd2 | 2024-09-17 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | NorthStar RxLLC | ea3259d5-36ee-4ac9-b849-9625626e2187 | 2024-07-03 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Qilu Pharmaceutical Co., Ltd. | 6077f5c4-01d7-4c1d-97a0-cb859f98ce68 | 2024-06-28 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Proficient Rx LP | 024e8e9b-a4fc-4882-b080-c070467166a6 | 2024-01-01 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | NorthStar RxLLC | f4e41c2c-d32d-40c2-8afb-b6df998ba6b0 | 2023-10-10 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Lannett Company, Inc. | 002dd00f-7946-ea4f-e063-6294a90a5916 | 2023-07-10 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Bryant Ranch Prepack | 09e48e71-4dd2-4538-91d7-5b284f6647d8 | 2023-03-29 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Proficient Rx LP | ce66d545-015b-41d5-80c3-964d78e36bfd | 2023-02-01 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Dr. Reddy's Laboratories Ltd. | 9a57a63e-f856-aafa-037a-c08f2fea6496 | 2022-10-03 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Proficient Rx LP | 1f4a2eaf-3a12-4ebe-b97f-0a7bfbc32572 | 2022-10-01 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Proficient Rx LP | e40d54bf-7334-4418-8a87-ff85941adec1 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Proficient Rx LP | 61424fa3-b09a-4267-a208-a7c7c3f69fe5 | 2020-10-01 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Aphena Pharma Solutions - Tennessee, LLC | b6ec5610-b4a6-4646-954a-0fe8b1d3e143 | 2020-05-05 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Proficient Rx LP | 7772a4c2-1fb1-412b-9e3b-ef3d693517a2 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.